Get started
AARTI DRUGS LTD.AARTI DRUGS LTD.AARTI DRUGS LTD.

AARTI DRUGS LTD.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

AARTIDRUGS chart


Full chart

AARTIDRUGS upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪37.37 B‬ INR
Dividend yield (indicated)
0.24%
Price to earnings Ratio (TTM)
25.00
Basic EPS (TTM)
16.60 INR
Net income (FY)
‪1.71 B‬ INR
Revenue (FY)
‪25.21 B‬ INR
Shares float
‪34.41 M‬
Beta (1Y)
1.00

Employees


Employees (FY)
‪2.76 K‬
Change (1Y)
+172 +6.64%
Revenue / Employee (1Y)
‪9.13 M‬ INR
Net income / Employee (1Y)
‪620.63 K‬ INR

About AARTI DRUGS LTD.


Sector
Health Technology
CEO
Prakash Moreshwar Patil
Headquarters
Mumbai
Website
aartidrugs.co.in
Founded
1984
ISIN
INE767A01016
FIGI
BBG000CMRNH9
Aarti Drugs Ltd. engages in the development, manufacture and market of pharmaceutical products. The firm operates through the Out of India, and India geographical segments. Its products include active pharmaceutical ingredient, specialty chemicals, pharma intermediate, products under development, and product under pipeline. The company was founded on September 28, 1984 and is headquartered in Mumbai, India.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

AARTIDRUGS news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of AARTIDRUGS is 409.90 INR — it has decreased by −1.09% in the past 24 hours. Watch AARTI DRUGS LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange AARTI DRUGS LTD. stocks are traded under the ticker AARTIDRUGS.
AARTIDRUGS stock has fallen by −2.42% compared to the previous week, the month change is a −3.33% fall, over the last year AARTI DRUGS LTD. has showed a −21.17% decrease.
We've gathered analysts' opinions on AARTI DRUGS LTD. future price: according to them, AARTIDRUGS price has a max estimate of 555.00 INR and a min estimate of 555.00 INR. Watch AARTIDRUGS chart and read a more detailed AARTI DRUGS LTD. stock forecast: see what analysts think of AARTI DRUGS LTD. and suggest that you do with its stocks.
AARTIDRUGS reached its all-time high on Oct 8, 2020 with the price of 1,026.95 INR, and its all-time low was 3.95 INR and was reached on Feb 20, 2009. View more price dynamics on AARTIDRUGS chart.
See other stocks reaching their highest and lowest prices.
AARTIDRUGS stock is 2.47% volatile and has beta coefficient of 1.00. Track AARTI DRUGS LTD. stock price on the chart and check out the list of the most volatile stocks — is AARTI DRUGS LTD. there?
Today AARTI DRUGS LTD. has the market capitalization of ‪37.37 B‬, it has decreased by −7.43% over the last week.
Yes, you can track AARTI DRUGS LTD. financials in yearly and quarterly reports right on TradingView.
AARTI DRUGS LTD. is going to release the next earnings report on Jan 29, 2025. Keep track of upcoming events with our Earnings Calendar.
AARTIDRUGS earnings for the last quarter are 3.90 INR per share, whereas the estimation was 3.90 INR resulting in a 0.07% surprise. The estimated earnings for the next quarter are 3.70 INR per share. See more details about AARTI DRUGS LTD. earnings.
AARTI DRUGS LTD. revenue for the last quarter amounts to ‪5.98 B‬ INR, despite the estimated figure of ‪5.83 B‬ INR. In the next quarter, revenue is expected to reach ‪5.79 B‬ INR.
AARTIDRUGS net income for the last quarter is ‪350.06 M‬ INR, while the quarter before that showed ‪332.41 M‬ INR of net income which accounts for 5.31% change. Track more AARTI DRUGS LTD. financial stats to get the full picture.
As of Jan 26, 2025, the company has ‪2.76 K‬ employees. See our rating of the largest employees — is AARTI DRUGS LTD. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AARTI DRUGS LTD. EBITDA is ‪2.88 B‬ INR, and current EBITDA margin is 12.70%. See more stats in AARTI DRUGS LTD. financial statements.
Like other stocks, AARTIDRUGS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AARTI DRUGS LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AARTI DRUGS LTD. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AARTI DRUGS LTD. stock shows the sell signal. See more of AARTI DRUGS LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.